Search results for "Drug Interactions"
MKSAP Quiz: Evaluation for confusion
A 63-year-old man is evaluated in the ED for confusion. He recently visited an urgent care center for symptoms of an upper respiratory tract infection and was prescribed codeine-guaifenesin. Following a physical exam and administration of naloxone, what is the most likely cause of this patient's adverse drug reaction?
https://immattersacp.org/weekly/archives/2022/12/06/4.htm
6 Dec 2022
Panel issues updated guidance on ART for HIV treatment, prevention
The recommendations from the International Antiviral Society-USA cover initiation of antiretroviral therapy (ART), switching regimens, ART in older patients with HIV, and HIV and COVID-19, among other topics.
https://immattersacp.org/weekly/archives/2022/12/06/1.htm
6 Dec 2022
Experts cover common COVID-19 challenges
A recent ACP/Annals of Internal Medicine forum on COVID-19 considered the timing of vaccination, outpatient treatment, and pre-exposure prophylaxis.
https://immattersacp.org/archives/2022/10/experts-cover-common-covid-19-challenges.htm
1 Oct 2022
IDSA offers guidance on managing drug interactions with nirmatrelvir/ritonavir
The Infectious Diseases Society of America (IDSA) listed six steps to help clinicians prescribe the COVID-19 medication while minimizing interaction risks. Other recent research looked at neuropsychiatric conditions after COVID-19 and hospital profits during the pandemic.
https://immattersacp.org/weekly/archives/2022/05/17/2.htm
17 May 2022
Managing DOACs in primary care
Primary care physicians play a crucial role in ongoing anticoagulation management, including educating patients about the signs of venous thromboembolism.
https://immattersacp.org/archives/2022/04/managing-doacs-in-primary-care.htm
1 Apr 2022
Recommendations on avoiding drug-drug interactions, data on recovery after ventilation
A panel of experts offered advice on avoiding drug-drug interactions when prescribing nirmatrelvir-ritonavir for patients with COVID-19, and two studies offered good news about postdischarge outcomes in COVID-19 patients who underwent a tracheostomy.
https://immattersacp.org/weekly/archives/2022/03/01/4.htm
1 Mar 2022
When to test, isolate, prescribe for outpatient COVID-19
Panelists at ACP and Annals of Internal Medicine's eighth virtual forum on COVID-19 discussed the latest recommendations and treatment options.
https://immattersacp.org/archives/2022/03/when-to-test-isolate-prescribe-for-outpatient-covid-19.htm
1 Mar 2022
New research on Pfizer pill, mental disorders after COVID-19, vaccine reactions
A manufacturer-funded trial quantified the effectiveness of nirmatrelvir/ritonavir in outpatients. A retrospective study found veterans had more mental health diagnoses and received more antidepressants, benzodiazepines, and opioids after COVID-19, while two other studies looked at reactions to second and third doses of the vaccines.
https://immattersacp.org/weekly/archives/2022/02/22/1.htm
22 Feb 2022
Detecting depression just as important in the elderly
Raising the issue of mental health is key in the elderly, by asking patients how often they talk to other people, if they're getting help with daily activities, or if they are feeling isolated.
https://immattersacp.org/archives/2022/02/detecting-depression-just-as-important-in-the-elderly.htm
1 Feb 2022
New recommendations for high-risk outpatients; data on omicron and boosters, breakthrough infections, myocarditis
The NIH updated its COVID-19 treatment guidelines for high-risk outpatients in response to the omicron variant, recommending the combination of ritonavir-nirmatrelvir above other options, and studies showed the effect of a booster dose. ACP practice points and new research looked at immunity conferred by infection or vaccination. Two studies quantified association of carditis with the mRNA vaccines.
https://immattersacp.org/weekly/archives/2022/01/25/1.htm
25 Jan 2022